HCPCS Level II J0485: Belatacept Injection, 1 mg
HCPCS Level II code J0485 represents the drug injection belatacept, billed per 1 mg unit for intravenous immunosuppressive therapy; the service is an injectable biologic medication typically administered in an outpatient infusion center or hospital outpatient department for prevention of organ rejection in transplant recipients.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J0485 policy alerts
Get alerted when payer policies referencing J0485 are released or updated.
Monitor payer policy activity